Smarter AnalystPatient Death Does Not Augur Doom, But Kite Pharma Needs To Shut Its Big MouthForbesI believe this is biology's century. I've covered science and medicine for Forbes from the Human Genome Project through Vioxx to the blossoming DNA technology changing the world today. Email me, follow me on Twitter, circle me onGoogle Plus, ...Kite Pharma Provides Update on KTE-C19 Clinical TrialCNNMoneyUPDATED: Heard the latest Kite Pharma rumor? CEO says it ain't soFierceBiotechKite Pharma Updates Study, Dispells Rumors24/7 Wall St.Seeking Alpha -Investor's Business Dailyall 10 news articles »
Patient Death Does Not Augur Doom, But Kite Pharma Needs To Shut Its Big Mouth
Rating: 4.5
Diposkan Oleh: Unknown
